ERBB2 and breast neoplasm: These results collectively suggest that the HER2+/PIK3CAmut breast tumor cells are associated with a state of elevated CPT1A activity and a robust lipid utilization, both of which are connected to mTOR and are inhibited by mTOR-KIs or rapamycin.